Clinical trial of AEF0217 for cognitive function in Down Syndrome shows promise
Bharti Jayshankar December 17, 2024: The ICOD (Improving Condition in Down Syndrome) project has reported promising findings from its phase 1/2 clinical trial
Bharti Jayshankar December 17, 2024: The ICOD (Improving Condition in Down Syndrome) project has reported promising findings from its phase 1/2 clinical trial
HQ Team December 17, 2024: In a study conducted in Churchill, Manitoba—often dubbed the “Polar Bear Capital of the World”—researchers from Dalhousie University
HQ Team December 16, 2024: The 2023 World Air Quality Report, released by Swiss air quality technology company IQAir, revealed that only seven
Bharti Jayshankar December 16, 2024: Researchers at the Rajiv Gandhi Biotechnology Centre, Kerala, delving into the molecular mechanisms of tumorigenesis by BRCA1 gene,
HQ Team December 13, 2024: The Institute for Clinical and Economic Review (ICER) has released a new report revealing that five high-expenditure drugs
Bharti Jayshankar December 13, 2024: AstraZeneca and Merck have announced long-term results from the OlympiA Phase 3 trial, showing that Lynparza (olaparib) significantly
HQ Team December 12, 2024: Filamon Limited, an Australian biotech company, has announced a significant advancement in dementia treatment with its new drug,
About one person every second or 42 million people each year are estimated to contract genital herpes infection worldwide, according to the World